STING1 and neoplasm: Additionally, while NAM activates the STING pathway to enhance immune responses, its combination with PARPi may disrupt immune cell balance in the tumor microenvironment by promoting regulatory T cell (Treg) proliferation, thereby potentially compromising anti-tumor immunity [64].